With 25+ years’ experience working in the pharmaceutical/biotech industries, Robert Ashton is a highly motivated, senior-level, team-oriented leader with a proven track record and progressive experience in all phases of marketing, strategic and commercial planning, market research, sales, and operations. He has demonstrated strengths in strategic marketing, product launch/commercialization, lifecycle planning and management, brand plan development and implementation, team leadership, and customer experience across a variety of therapeutic areas and business models.
Robert’s therapeutic-area experience spans across cardiology, respiratory, neurology, urology/men’s health, women’s health, anti-infectives, pain management, vaccines, and medical devices. His specific brand experience has included blockbusters such as Lipitor® (atorvastatin) and Cialis® (tadalafil) as well as niche brands Yupelri® (revefenacin) and Vibativ® (televancin). Pipeline assessments and lifecycle planning experience include molecules in development for benign prostatic hyperplasia (BPH), orthostatic hypotension, and LOE in various therapies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.